Personalized cancer cell therapy trial halted after single patient
NCT ID NCT05868915
Summary
This early-stage study tested a personalized cell therapy called HV-101 for adults with advanced solid tumors that had returned or spread. Doctors planned to extract immune cells from a patient's own tumor, grow them in a lab, and reinfuse them to fight the cancer. The trial was terminated after enrolling only one participant, so no conclusions about safety or effectiveness could be reached.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
Conditions
Explore the condition pages connected to this study.